[1] KUMAR V. Hydrazone:A promising pharmacophore in medicinal chemistry[J]. J Pharmacogn Phytochem, 2018, 7(2):40-43.
[2] JADNA SILVA FREDERICO M, JHONATAN GOMES CASTRO A, MASCARELLO A, et al. Acylhydrazones contribute to serum glucose homeostasis through dual physiological targets[J]. Curr Top Med Chem, 2012, 12(19):2049-2058.
[3] CERQUEIRA J V, MEIRA C S, DE SOUZA SANTOS E, et al. Anti-inflammatory activity of SintMed65, an N-acylhydrazone derivative, in a mouse model of allergic airway inflammation[J]. Int Immunopharmacol, 2019, 75:105735.
[4] ISSA S, PRANDINA A, BEDEL N, et al. Carbazole scaffolds in cancer therapy:a review from 2012 to 2018[J]. J Enzyme Inhib Med Chem, 2019, 34(1):1321-1346.
[5] LI Y J, WANG S Y, JIN K, et al. Synthesis and Cdc25B/PTP1B inhibitory activity evaluation of novel acylhydrazone derivatives containing carbazole moity[J]. Chin J Org Chem, 2019, 39(2):491-499. 李英俊, 王思远, 靳焜, 等. 新型含咔唑环酰腙衍生物的合成及Cdc25B/PTP1B抑制活性评价[J]. 有机化学, 2019, 39(2):491-499.
[6] LI Y J, ZHAO Y, JIN K, et al. Synthesis and PTP1B/TCPTP Inhibitory Activity Evaluation of Novel 2,5-Disubstituted-1,3,4-thiadiazolamide Derivatives Containing Carbazole/Benzimidazole Moity[J]. Chin J Org Chem, 2019, 39(9):2599-2608. 李英俊, 赵月, 靳焜, 等. 含咔唑/苯并咪唑环的2,5-二取代-1,3,4-噻二唑酰胺衍生物的合成及对PTP1B/TCPTP抑制活性的评价[J]. 有机化学, 2019, 39(9):2599-2608.
[7] TANG Y B, LIU J Z, ZHANG S E, et al. 3-Phenylpropanoic acid-based phosphotyrosine (pTyr) mimetics:Hit evolution to a novel orally active protein tyrosine phosphatase 1B (PTP1B) inhibitor[J]. Chem Med Chem, 2014, 9(5):918-921.
[8] CARUSO A, CERAMELLA J, IACOPETTA D, et al. Carbazole derivatives as antiviral agents:An overview[J]. Molecules, 2019, 24(10):1912.
[9] SHAIKH M S, KANHED A M, CHANDRASEKARAN B, et al. Discovery of novel N-methyl carbazole tethered rhodanine derivatives as direct inhibitors of Mycobacterium tuberculosis InhA[J]. Bioorg Med Chem Lett, 2019, 29(16):2338-2344.
[10] TAMENE D, ENDALE M. Antibacterial activity of coumarins and carbazole alkaloid from roots of clausena anisata[J]. Adv Pharmacol Sci, 2019:5419854.
[11] MAHAPATRA D K, DADURE K M, SHIVHARE R S. Edema reducing potentials of some emerging Schiff's bases of murrayanine[J]. MOJ Bioorg Org Chem, 2018, 2(4):171-174.
[12] ZHANG Q, DING D, ZENG S X, et al. Structure and activity analysis of Inauhzin analogs as novel antitumor compounds that induce p53 and inhibit cell growth[J]. PLoS one, 2012, 7(10):e46294.
[13] ALI R, SAAD H. Synthesis of some novel fused pyrimido[4'',5'':5',6']-[1,2,4] triazino[3',4':3,4] [1,2,4] triazino[5,6-b]indoles with expected anticancer activity[J]. Molecules, 2018, 23(3):693.
[14] ZHAN J Y, MA K, ZHENG Q C, et al. Exploring the interactional details between aldose reductase (AKR1B1) and 3-mercapto-5H-1,2, 4-triazino[5,6-b]indole-5-acetic acid through molecular dynamics simulations[J]. J Biomol Struct Dyn, 2019, 37(7):1724-1735.
[15] RAHIM F, TARIQ S, TAHA M, et al. New triazinoindole bearing thiazole/oxazole analogues:Synthesis, α-amylase inhibitory potential and molecular docking study[J]. Bioorg Chem, 2019, 92:103284.
[16] SHRUTHI N, POOJARY B, KUMAR V, et al. Synthesis and biological evaluation of N-(substituted phenyl)-2-(5H-[1,2,4] triazino[5,6-b] indol-3-ylsulfanyl)acetamides as antimicrobial, antidepressant, and anticonvulsant agents[J]. Russ J Bioorg Chem, 2015, 41(2):223-230.
[17] SHELKE S M, BHOSALE S H, MAHADIK K R. 3-(5H-[1,2,4] Triazino[5,6-b]indol-3-ylthio)-N-(substituted phenyl)propionamides:Synthesis and antidepressant activity evaluation[J]. Der Pharma Chemica, 2010, 2(4):169-177.
[18] ASWAR U M, KALSHETTI P P, SHELKE S M, et al. Effect of newly synthesized 1,2,4-triazino[5,6-b]indole-3-thione derivatives on olfactory bulbectomy induced depression in rats[J]. Asian Pac J Trop Biomed, 2012, 2(12):992-998.
[19] KGOKONG J L, SMITH P P, MATSABISA G M. 1,2,4-Triazino[5,6-b]indole derivatives:effects of the trifluoromethyl group on in vitro antimalarial activity[J]. Bioorg Med Chem, 2005, 13(8):2935-2942.
[20] SIVENDRAN S, JONES V, SUN D, et al. Identification of triazinoindol-benzimidazolones as nanomolar inhibitors of the Mycobacterium tuberculosis enzyme TDP-6-deoxy-D-xylo-4-hexopyranosid-4-ulose 3,5-epimerase (RmlC)[J]. Bioorg Med Chem, 2010, 18(2):896-908.
[21] LI Y J, LIU X J, LIU J H, et al. Synthesis and PTP1B inhibitory activity evaluation of novel carbazole-based carbohydrazone derivatives[J]. Chin J Org Chem, 2020, 40(2):478-488. 李英俊, 刘雪洁, 刘季红, 等. 基于咔唑的新型碳酰腙衍生物的合成及PTP1B抑制活性评价[J]. 有机化学, 2020, 40(2):478-488.
[22] HAMID H M A. Functionalised 1,2,4-triazino[5,6-b]indoles[J]. J Chem Res, 2004, 2004(3):183-185.
[23] ZHOU M, EUN Y J, GUZEI I A, et al. Structure-activity studies of divin:an inhibitor of bacterial cell division[J]. ACS Med Chem Lett, 2013, 4(9):880-885.
[24] HIZLIATEŞ C G. Arylidene carbazole carbohydrazides:Synthesis and characterization[J]. Hacettepe J Biol Chem, 2018, 46(2):169-175.
[25] LI Y J, YANG K D, JIN K, et al. NMR study of a novel carbazole-isatin based bis-thiocarbohydrozone derivative[J]. Chinese J Magn Reson, 2019, 36(1):83-92.李英俊, 杨凯栋, 靳焜, 等. 基于咔唑-靛红双-硫代碳酰腙衍生物的NMR研究[J]. 波谱学杂志, 2019, 36(1):83-92.
[26] YIN T P, WANG Z, CHEN Y, et al. An NMR analysis of 10-indol cytochalasin chaetoglobosin F[J]. Chinese J Magn Reson, 2019, 36(1):74-82. 尹田鹏, 汪泽, 陈阳, 等. 10-吲哚细胞松弛素chaetoglobosin F的NMR解析[J]. 波谱学杂志, 2019, 36(1):74-82.
[27] LI Y J, LI J Y, JIN K, et al. An NMR study of a novel N-acylhydrazone derivative containing benzimidazole moiety[J]. Chinese J Magn Reson, 2017, 34(1):25-34.李英俊, 李继阳, 靳焜, 等. 含苯并咪唑环N-酰腙衍生物的NMR研究[J]. 波谱学杂志, 2017, 34(1):25-34.
